# Dare Bioscience, Inc.: Form 8-K, filed Sep 11, 2026

- Company: [Dare Bioscience, Inc.](/companies/dare.md) (CIK 1401914)
- Form: 8-K
- Filed: 2026-09-11
- Accepted by EDGAR: Sep 11, 2026, 16:29 ET
- Period: 2026-09-10
- Accession: 0001401914-26-000050
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401914/000140191426000050/dare-20260910.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401914/000140191426000050/

## Items reported

- Item 5.03: Amendment to articles or bylaws

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401914/000140191426000050/dare-20260910.htm

Filed Sep 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001401914-26-000050. Last ingested by Listed: Nov 12, 2026, 19:19 ET. No prices; not investment advice.
